WeVote

Bill

Bill

SB 662

Relating to colorectal cancer prevention

2026 Regular Session Introduced by Anne Charnock and 12 co-sponsors

West Virginia bill SB 662 establishes colorectal cancer prevention measures through screening and awareness initiatives referred to legislative committees for evaluation.

To Finance
0
WeVote Research Nonpartisan
Bill Summary · SB 662

Legislative bill overview

SB 662 is a West Virginia bill focused on colorectal cancer prevention measures. The bill has been introduced and referred to the Health and Human Resources Committee for review. As of the most recent filing, specific provisions have not been publicly detailed beyond the bill's general subject matter.

Why is this important

Colorectal cancer is the third leading cause of cancer deaths in the United States, making prevention and early screening policies significant public health priorities. State-level legislation addressing colorectal cancer prevention can expand screening access, improve public awareness, and potentially reduce mortality rates and healthcare costs through early detection.

Potential points of contention

  • Screening mandate scope – Whether the bill requires mandatory screening, recommends it, or focuses on insurance coverage, which affects implementation costs and individual choice
  • Funding mechanisms – How prevention programs will be financed and whether it creates new state budgetary obligations during committee review in Finance
  • Healthcare provider requirements – Potential burden on medical facilities and practitioners to comply with new screening protocols or reporting requirements

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.